SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cannabis Testing Industry Hit by Fraud Allegations in Equipment Dispute

    By

    More than two dozen cannabis testing laboratories are seeking a collective $1 billion in damages from a major medical-equipment manufacturer they claim sold them faulty gear under false promises.

    The suit, refiled in Suffolk County Superior Court in Massachusetts on July 24, accuses Massachusetts-based PerkinElmer Health Sciences, now known as Revvity Health Sciences, of undertaking a ‘knowingly and intentionally deceptive marketing and sales campaign’ to sell equipment it knew “could not – and w(as) not designed to” test cannabis, court documents show.

    Keith Bensten, the attorney of record for Revvity, did not immediately respond to an email seeking comment from MJBizDaily on Monday.

    In a June 18 response, made to an earlier version of the complaint first filed in January, the company rejected the fraud claims as ‘insufficient’ and ‘inadequate.’

     

    This story was originally published on MJBizDaily, click here to read on. 

    MJBizDaily

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free